Human Application Of Engineered Chimeric Antigen Receptor (Car) T-Cells
Patent No. EP2997134 (titled "Human Application Of Engineered Chimeric Antigen Receptor (Car) T-Cells") was filed by Board OF Regents on May 14, 2014. The application was issued on Jun 24, 2020.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP2997134
- Application Number
- EP14798046A
- Filing Date
- May 14, 2014
- Status
- Revoked
- Dec 3, 2021
- Publication Date
- Jun 24, 2020
- External Links
- Slate, Register , Google Patents